These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36538301)

  • 1. Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay.
    Salvagno GL; Henry BM; De Nitto S; Pighi L; Lippi G
    New Microbiol; 2022 Dec; 45(4):353-354. PubMed ID: 36538301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracy.
    Lippi G; Henry BM; Adeli K; Plebani M
    Diagnosis (Berl); 2022 Mar; 9(2):149-156. PubMed ID: 35287253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens.
    Baccani I; Morecchiato F; Chilleri C; Cervini C; Gori E; Matarrese D; Bassetti A; Bonizzoli M; Mencarini J; Antonelli A; Rossolini GM
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115434. PubMed ID: 34174523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups.
    Menchinelli G; Bordi L; Liotti FM; Palucci I; Capobianchi MR; Sberna G; Lalle E; Romano L; De Angelis G; Marchetti S; Sanguinetti M; Cattani P; Posteraro B
    Clin Chem Lab Med; 2021 Jul; 59(8):1468-1476. PubMed ID: 33823089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
    Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
    Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Hirotsu Y; Sugiura H; Maejima M; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Jul; 108():263-269. PubMed ID: 34082089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Plebani M; Lippi G
    Clin Chem Lab Med; 2023 Jul; 61(8):1506-1510. PubMed ID: 36883744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
    Orsi A; Pennati BM; Bruzzone B; Ricucci V; Ferone D; Barbera P; Arboscello E; Dentone C; Icardi G
    J Virol Methods; 2021 Sep; 295():114201. PubMed ID: 34058287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Sberna G; Basile F; Guarino ML; Capobianchi MR; Bordi L; Parisi G
    Int J Infect Dis; 2021 Dec; 113():113-115. PubMed ID: 34597768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay.
    Salvagno GL; Gianfilippi G; Fiorio G; Pighi L; De Nitto S; Henry BM; Lippi G
    EJIFCC; 2021 Jun; 32(2):216-223. PubMed ID: 34421491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens.
    Salvagno GL; Henry BM; de NS; Pighi L; Lippi G
    J Med Biochem; 2022 Oct; 41(4):513-517. PubMed ID: 36381068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis.
    Ishii T; Sasaki M; Yamada K; Kato D; Osuka H; Aoki K; Morita T; Ishii Y; Tateda K
    J Infect Chemother; 2021 Jun; 27(6):915-918. PubMed ID: 33676843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
    Basso D; Aita A; Padoan A; Cosma C; Navaglia F; Moz S; Contran N; Zambon CF; Maria Cattelan A; Plebani M
    Clin Chim Acta; 2021 Jun; 517():54-59. PubMed ID: 33626369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical performance evaluation of Lumipulse® SARS-CoV-2 antigen assay in 392 asymptomatic patients.
    Petruzziello A; Sabatino R; Catapane LA; De Falco C; Petti A; Tripaldelli E; Loquercio G; Annecchiarico A; Salzillo A; Caradonna E; Maggi P
    J Clin Lab Anal; 2023 Mar; 37(6):e24867. PubMed ID: 36972465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.